Search bioRxiv⌕ Search

Biology subjects

Eich, C.

Publications and source records attributed to Eich, C..

3 recordsLinked to original sources

Elemental allocation to molecular drivers of biogeochemistry in the Southern Ocean

Metabolic processes underpinning ocean biogeochemistry are powered by molecular machines, proteins, that require various elements to function. Yet, the allocation of elements to these proteins, and subsequent implications for biogeochemical processes, remain poorly characterized. Here we integrate elemental measurements with metaproteomics to quantitatively examine elemental use in Southern Ocean microbial proteins and metabolic processes. We demonstrate that iron availability influences elemental allocation, including decreased iron allocation to photosynthesis and compensatory incorporation of non-iron metals into metalloproteins under iron scarcity. Manganese was primarily allocated to photosynthesis in iron-replete conditions, and reallocated to other metabolic roles under low iron. Photosystem I:II protein mass ratios impacted both iron and manganese allocation, and appeared to be driven by iron availability. Approximately half of biogenic copper was found in plastocyanin, likely substituting for iron-containing cytochromes in photosynthesis. Moreover, biogenic nitrogen to phosphorus ratios were decoupled from ribosomal abundance, contrary to prevailing assumptions about ribosomal influence on stoichiometric regulation in the ocean. Instead, our results suggest that community composition and intracellular storage are important regulators of N:P in the Southern Ocean. Together, our findings identify key molecular mechanisms that modulate elemental demand and limitation, and provide a foundation for quantitatively connecting molecular measurements with biogeochemical models.

microbiology↗

An EGF-modified PLGA-lanthanide nano platform for combined NIR-II cancer imaging and targeted drug delivery

The use of multifunctional nanoplatforms for synergistic therapy and imaging is a promising approach in cancer treatment. In this study, we exploited the imaging properties of lanthanides by encapsulating CaF2:Y, Nd along with the chemotherapeutic drug doxorubicin (DOX) into poly (D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) to prepare a nanoplatform suitable for imaging in the second near-infrared (NIR-II) window and simultaneous anti-cancer therapy. To facilitate the accumulation of CaF2:Y, Nd+DOX@PLGA NPs in breast cancer cells, we modified the NPs with EGF. The diameter of the obtained CaF2:Y, Nd+DOX@PLGA/PEG/EGF NPs was approximately 150 nm, with a nearly round shape and homogeneous size distribution. In addition, analysis of the drug release behaviour showed that DOX was released more readily and had a longer release time in acidic environments. Accordingly, MTS results indicated that DOX-loaded NPs were significantly cytotoxic. Furthermore, fluorescence microscopy and flow cytometry studies revealed that CaF2:Y, Nd+DOX@PLGA/PEG and CaF2:Y, Nd+DOX@PLGA/PEG/EGF NPs were gradually taken up by 4T1 breast cancer cells over time, and EGF-coated Nd+DOX@PLGA NPs exhibited increased uptake rates after 72 h. Moreover, we found that EGF increased the solubility of Nd+DOX@PLGA NPs in water by comparing the aqueous solutions of the different NPs formulations. Finally, NIR imaging demonstrated strong fluorescence of PLGA NPs carrying CaF2:Y, Nd NPs at 900-1200 nm under 808 nm laser excitation. In conclusion, the developed CaF2:Y, Nd+DOX@PLGA/PEG/EGF NPs could be monitored for an extended period of time, and co-encapsulated DOX could be efficiently released to kill breast cancer cells.

cancer biology↗

Triplet-Triplet Annihilation PLGA-Nanoparticles for Cancer Bioimaging

Triplet-triplet annihilation upconversion (TTA-UC) nanoparticles (NPs) have emerged as imaging probes and therapeutic probes in recent years due to their excellent optical properties. In contrast to lanthanide ions-doped inorganic materials, highly efficient TTA-UC can be generated by low excitation power density, which makes it suitable for clinical applications. In the present study, we used biodegradable poly(lactic-co-glycolic acid) (PLGA)-NPs as delivery vehicle for TTA-UC based on the heavy metal porphyrin Platinum(II) octaethylporphyrin (PtOEP) and the polycyclic aromatic hydrocarbon 9,10-diphenylanthracene (DPA) as photosensitizer/emitter pair. TTA-UC-PLGA-NPs were successfully synthesized according to an oil-in-water emulsion and solvent evaporation method. After physicochemical characterization, UC-efficacy of TTA-UC-PLGA-NPs was assessed in vitro and ex vivo. TTA-UC could be detected in the tumor area 96 hours after in vivo administration of TTA-UC-PLGA-NPs, confirming the integrity and suitability of PLGA-NPs as TTA-UC in vivo delivery system. Thus, this study provides proof-of-concept that the advantageous properties of PLGA can be combined with the unique optical properties of TTA-UC for the development of advanced nanocarriers for simultaneous in vivo molecular imaging and drug delivery.

bioengineering↗